Comparing Biomarkers as Principal Surrogate Endpoints
From MaRDI portal
Publication:2893405
DOI10.1111/J.1541-0420.2011.01603.XzbMath1274.62793OpenAlexW2002963026WikidataQ28740935 ScholiaQ28740935MaRDI QIDQ2893405
Publication date: 20 June 2012
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3163011
semiparametricprincipal stratificationpredictiveness curveestimated likelihoodsurrogate markertotal gain
Related Items (10)
A unified evaluation of differential vaccine efficacy ⋮ Evaluating multiple surrogate markers with censored data ⋮ Robust Approach to Combining Multiple Markers to Improve Surrogacy ⋮ Testing for Heterogeneity in the Utility of a Surrogate Marker ⋮ Assessing the value of a censored surrogate outcome ⋮ A Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference Framework ⋮ Identification of causal effects within principal strata using auxiliary variables ⋮ Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials ⋮ Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling ⋮ Surrogate Measures and Consistent Surrogates
Cites Work
- Unnamed Item
- The evaluation of surrogate endpoints.
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
- Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials
- Principal Stratification in Causal Inference
- Evaluating Candidate Principal Surrogate Endpoints
- A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials
- Related Causal Frameworks for Surrogate Outcomes
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- Semiparametric Estimation of Regression Quantiles with Application to Standardizing Weight for Height and Age in US Children
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Weighted Likelihood for Semiparametric Models and Two‐phase Stratified Samples, with Application to Cox Regression
- Evaluating the Predictiveness of a Continuous Marker
This page was built for publication: Comparing Biomarkers as Principal Surrogate Endpoints